An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients

Inclusion criteria: * Histologically confirmed diagnosis of adenocarcinoma of the prostate gland via a minimum of 6 core biopsy samples. * Subjects must be a candidate for radical prostatectomy * No evidence of metastatic disease as determined by CT scans and bone scans * More criteria apply Exclusion Criteria: * Subjects from whom sufficient diagnostic biopsy material is not available for full characterization of the tumor * Active Infection requiring antibiotic therapy, or serious intercurrent illness, active bleeding, or ongoing urinary tract infection necessitating rapid or emergent surgical resection * Subjects who have had hormonal injection or implants which will last longer than 6 months * More criteria apply